Considerable disturbances of cardiovascular risk factors in women with diabetes and myocardial infarction

https://doi.org/10.1016/j.jdiacomp.2003.10.001Get rights and content

Abstract

Objective

To investigate to which extent differences in cardiovascular risk factors explain the increased risk of myocardial infarction (MI) and complication rate in women with diabetes mellitus (DM).

Design

Case-control study.

Subjects

We compared women with diabetes and previous MI (n=29), diabetes but no MI (n=46), prior MI but no diabetes (n=64), and healthy controls (n=125).

Measurements

Smoking habits, physical activity, blood pressure (BP), body mass index (BMI), waist/hip ratio (WHR), serum lipids, plasma fibrinogen, and serum sex hormones.

Results

Despite the fact that diabetic women had similar BMI, those with a past MI, compared to diabetic women without MI, had significantly higher WHR (mean, 95% CI) [0.89 (0.87, 0.92) vs. 0.84 (0.81, 0.86) mmol/l, P=.001] and very high S-triglycerides [3.03 (2.23, 3.83) vs. 1.69, (1.39, 1.99) mmol/l, P=.001] and low HDL-cholesterol [1.09 (0.94, 1.24) vs. 1.56 (1.41, 1.71) mmol/l, P<.001], indicating pronounced metabolic disturbances. Women with MI but no diabetes had intermediate values for WHR, triglycerides, and HDL-cholesterol. Furthermore, women with diabetes and MI had significantly higher p-fibrinogen, were smokers, and lived a more sedentary life than the other women. Over half of all women with prior MI were on lipid-lowering therapy and tended to have nonsignificantly lower S-cholesterol than women without MI.

Conclusions

Women with diabetes who have manifested an MI carry a very substantial cardiovascular risk factor burden, which probably explain their increased morbidity and mortality. In order to improve prognosis, studies targeted at investigating treatment modalities for these abnormalities are needed.

Introduction

In addition to smoking, hypertension, and hyperlipidemia, diabetes mellitus (DM) is a strong risk factor for the development of cardiovascular disease (CVD). While the prevalence of diabetes is 3–4% in the general Swedish population Andersson et al., 1991, Eliasson et al., 2002, 20–25% of patients with myocardial infarction (MI) have known diabetes Abbud et al., 1995, Löwel et al., 2000, Lundberg et al., 1997, Malmberg et al., 2000, Norhammar et al., 2002. Consequently, a considerable amount of diabetic patients, numbers of 50–70% are usually given, are affected by CVD and especially coronary heart disease (CHD) during their life span. Previous studies have shown several times increased risk of primary and recurrent MI and of cardiovascular mortality in diabetic compared to nondiabetic subjects Abbott et al., 1988, Abbud et al., 1995, Adlerberth et al., 1998, Barrett-Connor et al., 1991, Chun et al., 1997, Haffner et al., 1998, Hanefeld et al., 1996, Kanaya et al., 2002, Krolewski et al., 1987, Lee et al., 2000, Lehto et al., 1994, Löwel et al., 2000, Malmberg et al., 2000, Miettinen et al., 1998, Ulvenstam et al., 1985, Vilbergsson et al., 1998.

During the last decades, mortality from CHD has declined in the Western populations. However, this improvement has not occurred in diabetic patients Chun et al., 1997, Gu et al., 1999. Furthermore, the difference in CHD morbidity and mortality between diabetic and nondiabetic individuals seems to be more prominent in women than in men Abbott et al., 1988, Barrett-Connor et al., 1991, Benderly, et al., for the SPRINT study group, 1997, Chun et al., 1997, Lee et al., 2000, Lehto et al., 1994, Malmberg et al., 2000, Miettinen et al., 1998, although conflicting results have been reported Abbud et al., 1995, Kanaya et al., 2002, Krolewski et al., 1987, Löwel et al., 2000, Vilbergsson et al., 1998. However, the inconsistent findings may be explained by different ways of analysing morbidity and mortality (Kanaya et al., 2002).

Women with diabetes surviving an MI appear to have a more unfavourable prognosis than diabetic men Abbott et al., 1988, Benderly, et al., for the SPRINT study group, 1997, Chun et al., 1997, although some studies did not show any major differences (Abbud et al., 1995). Some authors claim that DM, besides older age, is the main reason for the increased mortality in women surviving an MI (Benderly et al., 1997).

Infarct size does not differ or is smaller in diabetic compared to nondiabetic MI patients Lehto et al., 1994, Löwel et al., 2000, Miettinen et al., 1998. However, angiographic studies have shown a more severe and extensive type of coronary artery disease in patients with both types 1 and 2 diabetes compared to patients without diabetes, with particularly marked differences in women Natali et al., 2000, Pajunen et al., 2000. This might explain the increased incidence of congestive heart failure (CHF) in diabetic women Abbott et al., 1988, Lehto et al., 1994.

In previous studies, increased levels of serum total cholesterol, LDL-cholesterol, triglycerides (TG), and blood pressure (BP) and lower HDL-cholesterol were reported in diabetic compared to nondiabetic subjects. However, few studies have investigated to what extent major CHD risk factors contribute to the risk of MI in women with diabetes (Barrett-Connor et al., 1991). The aim of the present case-control study was to estimate the CHD risk factor burden in women with diabetes, MI, or both compared to healthy women and to investigate to what extent the differences in risk factors might explain the increased MI risk and complication rate in women with diabetes.

Section snippets

MI women with and without diabetes

Göteborg, the second largest city of Sweden, has a population of about 450,000. The Göteborg Myocardial Infarction Register, which started in 1968, monitors all events of MI and deaths from CHD in individuals below 65 years of age in the city (Elmfeldt et al., 1975). All surviving women below the age of 65 years, who had been hospitalised with an MI in any of the two Göteborg hospitals in 1994 to 1996 (n=116), were invited to participate in the study. MI was considered to have occurred when at

Methods

The screening methods for the MONICA study were used also for the MI and diabetic women and are described in detail elsewhere (Wilhelmsen et al., 1997). Briefly, an invitation letter with information about the study and a postal questionnaire about present and past health status, smoking habits, medication, and physical activity were sent to the participants. The women were examined between 8 and 10 am after an overnight fast.

Smoking habits were graded as (1) current smokers, (2) ex-smokers of

Characteristics of study subjects

Table 1 shows the number of invited and participating women in each group. Age, smoking habits, menopausal state, age at menopause, physical activity, diabetes duration, HbA1c, and treatment with lipid lowering and antihypertensive therapy are shown in Table 2. Mean age was lower among the healthy control women, as in the MONICA study, similar numbers of women in the 10-year age groups 45–54 and 55–64 years were included. Among the patients, who were included consecutively, 4 (13.8%) of the

Discussion

Although the absolute hazard of MI in women is low until older age (Rosengren et al., 2001), a history of DM or previous MI greatly increases the risk. Women with diabetes are thereby more similar to men with and without diabetes than nondiabetic women (Barrett-Connor et al., 1991). It is not known whether any single, particular factor explains why women with diabetes lose their protection against MI or if, simply, the burden of all risk factors combined accelerate the atherosclerotic process

Acknowledgements

This study was supported by grants from the Swedish Heart and Lung Foundation, The Swedish Medical Research Council, the Swedish Council for Planning and Co-ordination of Research (FRN), and The Göteborg Medical Society.

References (47)

  • E.L. Barrett-Connor et al.

    Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study

    JAMA

    (1991)
  • M. Benderly et al.

    Long-term prognosis of women after myocardial infarction

    American Journal of Epidemiology

    (1997)
  • G. Bruno et al.

    Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin dependent diabetes mellitus

    Annals of Internal Medicine

    (1996)
  • B.Y. Chun et al.

    The impact of diabetes on survival among patients with first myocardial infarction

    Diabetes Care

    (1997)
  • A. Clauss

    Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens

    Acta Haematologica (Basel)

    (1957)
  • C. el Khawand et al.

    Hemostasis variables in type 1 diabetic patients without demonstrable vascular complications

    Diabetes Care

    (1993)
  • M. Eliasson et al.

    No increase in the prevalence of known diabetes between 1986 and 1999 in subjects 25–64 years of age in northern Sweden

    Diabetic Medicine

    (2002)
  • D. Goodman-Gruen et al.

    A prospective study of sex-hormone binding globulin and fatal cardiovascular disease in Rancho Bernardo men and women

    Journal of Clinical Endocrinology and Metabolism

    (1996)
  • D. Goodman-Gruen et al.

    Sex hormone-binding globulin and glucose tolerance in postmenopausal women

    Diabetes Care

    (1997)
  • K. Gu et al.

    Diabetes and decline in heart disease mortality in US adults

    JAMA

    (1999)
  • S.M. Haffner et al.

    Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

    New England Journal of Medicine

    (1998)
  • M. Hanefeld et al.

    Risk factors for myocardial infarction and death in newly detected NIDDM: the diabetes intervention study, 11 year follow up

    Diabetologia

    (1996)
  • A.M. Kanaya et al.

    Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis

    Archives of Internal Medicine

    (2002)
  • Cited by (0)

    View full text